Jan De Nul Group receives Randstad Award
Jan De Nul Group as the most appealing employer
During the third term of 2008, 10.000 persons between 18 and 65 years old were asked for their opinion about Belgian employers: for which company you would like to work and what makes it so attractive? ICMA International listed only companies with more than 1000 employees. This poll showed that Jan De Nul Group is seen as the most appealing employer. The company ended a few times in the top 10 during previous years, but gained this year the ultimate recognition with the Randstad Award.
Job security above high wage
Jan De Nul Group, a construction and dredging company with its Belgian office in Aalst, scores excellently for job security, perspectives and combination work and private matters. The victory is partly attributed to the high level of job security which Jan De Nul Group can offer to its employees. The current investment policy of the company, with more than 20 vessels in the pipeline, gives a clear signal to the world that Jan De Nul, especially in these times, does not fear such challenge. The fact that job security gets the advantage is due to the current economic recession. Nowadays employees prefer a steady job with perspectives above a high wage.
Because of continuous recruitment campaigns in the course of 2008 as well, Jan De Nul has gained familiarity. 2009 promises to show the same trend.
Randstad AwardThe Randstad Award, with the support of VBO
Each year Randstad gives out this Award to the most appealing employer of the country. Last year GlaxoSmithKline and Techspace Aero had this honor. The otherwise so appealing sectors lose standing because of reorganizations and the financial crisis. This year the Randstad Award has been organized for the first time with the support of VBO (Federation of Belgian Industries), showing a clear statement: this Award is of great importance for every Belgian employer in times of scarcity at the labour market and economic recession. Companies must guard their image as an employer, if they want to cope with these factors. The companies GlaxoSmithKline, PricewaterhouseCoopers and Janssen Pharmaceutica ended respectively at the second, third and fourth place.